The impact of the implementation of medication for opioid use disorder and COVID-19 in a statewide correctional system on treatment engagement, postrelease continuation of care, and overdose

BACKGROUND: People with opioid use disorder (OUD) are overrepresented in US correctional facilities and experience disproportionately high risk for overdose after release. Medications for OUD (MOUD) are highly efficacious but not available to most incarcerated individuals. In 2018, Vermont began pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Klemperer, Elias M., Wreschnig, Laura, Crocker, Abigail, King-Mohr, Jessica, Ramniceanu, Annie, Brooklyn, John R., Peck, Kelly R., Rawson, Richard A., Evans, Elizabeth A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257572/
https://www.ncbi.nlm.nih.gov/pubmed/37311520
http://dx.doi.org/10.1016/j.josat.2023.209103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257572/
https://www.ncbi.nlm.nih.gov/pubmed/37311520
http://dx.doi.org/10.1016/j.josat.2023.209103

Ejemplares similares